Attitudes and Practices of a Sample of Nova Scotian Physicians for the Implementation of HIV Pre-Exposure Prophylaxis

References

• Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973–1983. doi:10.1097/QAD.0000000000001145
   PubMed Web of Science ®Google Scholar
• Khurana N, Yaylali E, Farnham PG, et al. Impact of improved HIV care and treatment on PrEP effectiveness in the United States, 2016–2020. JAIDS J Acquir Immune Defic Syndr. 2018;78(4):399–405. doi:10.1097/QAI.0000000000001707
   Web of Science ®Google Scholar
• Grant R, Lama J, Anderson P, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men NEJM. N Engl J Med. 2010;363(27):2587–2599. doi:10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• CADTH. HIV pre-exposure prophylaxis with emtricitabine/tenofovir disoproxil fumarate — regulatory and reimbursement policies; 2017. Available from: https://cadth.ca/dv/hiv-pre-exposure-prophylaxis-emtricitabinetenofovir-disoproxil-fumarate-regulatory-and-reimbursement. Accessed January 29, 2020.
   Google Scholar
• Sharma M, Wilton J, Senn H, Fowler S, Tan DHS. Preparing for PrEP: perceptions and readiness of Canadian physicians for the implementation of HIV pre-exposure prophylaxis. PLoS One. 2014;9(8):e105283. doi:10.1371/journal.pone.0105283
   PubMed Web of Science ®Google Scholar
• Krakower DS, Mayer KH. The role of healthcare providers in the roll-out of PrEP. Curr Opin HIV AIDS. 2016;11(1):41–48. doi:10.1097/COH.0000000000000206
   PubMed Web of Science ®Google Scholar
• Adams LM, Balderson BH. HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016;28(9):1154–1158. doi:10.1080/09540121.2016.1153595
   PubMed Web of Science ®Google Scholar
• Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis. 2014;58(5):704–712. doi:10.1093/cid/cit796
   PubMed Web of Science ®Google Scholar
• Reyniers T, Vuylsteke B, Pirotte B, et al. Physicians’ preparedness for pre-exposure prophylaxis: results of an online survey in Belgium. Sex Health. 2018;15(6):606–611. doi:10.1071/SH18072
   PubMed Web of Science ®Google Scholar
• Walsh JL, Petroll AE. Factors related to pre-exposure prophylaxis prescription by U.S. primary care physicians. Am J Prev Med. 2017;52(6):e165–e172. doi:10.1016/j.amepre.2017.01.025
   PubMed Web of Science ®Google Scholar
• Blumenthal J, Jain S, Krakower D, et al. Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–810. doi:10.1007/s10461-015-0996-z
   PubMed Web of Science ®Google Scholar
• Tripathi A, Ogbuanu C, Monger M, Gibson J, Duffus W. Preexposure prophylaxis for HIV infection: healthcare providers’ knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J. 2012;105(4):199–206. doi:10.1097/SMJ.0b013e31824f1a1b
   PubMed Web of Science ®Google Scholar
• Bernaix LW. Nurses‘ attitudes, subjective norms, and behavioral intentions toward support of breastfeeding mothers. J Hum Lact. 2000;16(3):201–209. doi:10.1177/089033440001600304
   Google Scholar
• Godin G, Bélanger-Gravel A, Eccles M, Grimshaw J. Healthcare professionals‘ intentions and behaviours: a systematic review of studies based on social cognitive theories. Implement Sci. 2008;3(1):36. doi:10.1186/1748-5908-3-36
   PubMed Web of Science ®Google Scholar
• Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide medicare medication therapy management services using the theory of planned behavior. Res Soc Adm Pharm. 2006;2(3):299–314. doi:10.1016/j.sapharm.2006.02.008
   Google Scholar
• Haddad N, Li J, Totten S, McGuire M. HIV in Canada—surveillance report, 2017. Can Commun Dis Rep. 2018;44(12):348–356. doi:10.14745/ccdr.v44i12a03
   PubMedGoogle Scholar
• Government of Nova Scotia. Province marks HIV/AIDS awareness week and world AIDS day. News Releases; 2018. Available from: https://novascotia.ca/news/release/?id=20191128003. Accessed June 12, 2020.
   Google Scholar
• Field A. Discovering Statistics Using SPSS. 2nd ed. London: Sage; 2005.
   Google Scholar
• Pett M, Lackey N, Sullivan J. Making Sense of Factor Analysis: The Use of Factor Analysis for Instrument Development in Health Care Research. Thousand Oaks, California: Sage; 2003.
   Google Scholar
• O’Connor B. SPSS and SAS programs for determining the number of components using parallel analysis and Velicer’s MAP test. Behav Res Methods Instrum Comput. 2000;32(3):396–402. doi:10.3758/BF03200807
   PubMedGoogle Scholar
• George D, Mallery P. SPSS for Windows Step by Step: A Simple Guide and Reference.11.0 Update. 4th ed. Boston: Allyn & Bacon; 2003.
   Google Scholar
• Hayes AF, Cai L. Using heteroskedasticity-consistent standard error estimators in OLS regression: an introduction and software implementation. Behav Res Methods. 2007;39(4):709–722. doi:10.3758/BF03192961
   PubMed Web of Science ®Google Scholar
• Myers R, Myers R. Classical and Modern Regression with Applications. Belmont, California: Duxbury press; 1990.
   Google Scholar
• Tabachnick B, Fidell L. Using Multivariate Statistics. 6th ed. Pearson; 2013. Available from: https://www.pearson.com/us/higher-education/program/Tabachnick-Using-Multivariate-Statistics-6th-Edition/PGM332849.html. Accessed February 4, 2020.
   Google Scholar
• Iacobucci D. Mediation analysis and categorical variables: the final frontier. J Consum Psychol. 2012;22(4):582–594. doi:10.1016/j.jcps.2012.03.006
   Web of Science ®Google Scholar
• Tan DHS, Hull MW, Yoong D, et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ Can Med Assoc J. 2017;189(47):E1448–E1458. doi:10.1503/cmaj.170494
   PubMed Web of Science ®Google Scholar
• Petroll AE, Walsh JL, Owczarzak JL, et al. PrEP awareness, familiarity, comfort, and prescribing experience among us primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–1267. doi:10.1007/s10461-016-1625-1
   PubMed Web of Science ®Google Scholar
• Weiser J, Garg S, Beer L, Skarbinski J. Prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis by HIV medical providers in the United States, 2013–2014. Open Forum Infect Dis. 2017;4(1). doi:10.1093/ofid/ofx003
   Web of Science ®Google Scholar
• Hull M, Tan D. Setting the stage for expanding HIV pre-exposure prophylaxis use in Canada. Can Commun Dis Rep Releve Mal Transm Au Can. 2017;43(12):272–278. doi:10.14745/ccdr.v43i12a05
   PubMedGoogle Scholar
• Kelly JA. Ten things we need to do to achieve the goals of the end the HIV epidemic plan for America. J Acquir Immune Defic Syndr. 2019;82(Suppl 2):S94–S98. doi:10.1097/QAI.0000000000002166
   Web of Science ®Google Scholar
• Nelson LE, McMahon JM, Leblanc NM, et al. Advancing the case for nurse practitioner-based models to accelerate scale-up of HIV pre-exposure prophylaxis. J Clin Nurs. 2019;28(1–2):351–361. doi:10.1111/jocn.14675
   Web of Science ®Google Scholar
• Sharma M, Chris A, Chan A, et al. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol. BMC Health Serv Res. 2018;18(1):513. doi:10.1186/s12913-018-3324-2
   PubMed Web of Science ®Google Scholar
• Patel RR, Chan PA, Harrison LC, et al. Missed opportunities to prescribe HIV pre-exposure prophylaxis by primary care providers in Saint Louis, Missouri. LGBT Health. 2018;5(4):250–256. doi:10.1089/lgbt.2017.0101
   PubMed Web of Science ®Google Scholar
• Lord R. Nova scotia doctor shortage forces ongoing emergency department closures. globalnews.ca; 2019. Available from: https://globalnews.ca/news/5986086/nova-scotia-doctor-shortage-emergency-room-closures/. Accessed February 4, 2020.
   Google Scholar
• Nova Scotia Health Authority. Need a family practice data; 2020. Available from: http://www.nshealth.ca/need-family-practice-data. Accessed February 4, 2020.
   Google Scholar
• Schneidereit P. PAUL SCHNEIDEREIT: Nova Scotia’s family doctor shortage deepens outside Halifax | local-perspectives | opinion. The Chronicle Herald; 2019. Available from: https://www.thechronicleherald.ca/opinion/local-perspectives/paul-schneidereit-doctor-shortage-deepens-outside-halifax-378622/. Accessed February 4, 2020.
   Google Scholar
• Blackstock OJ, Patel VV, Felsen U, Park C, Jain S. Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic. AIDS Care. 2017;29(7):866–869. doi:10.1080/09540121.2017.1286287
   PubMed Web of Science ®Google Scholar
• Krakower DS, Ware NC, Maloney KM, et al. Differing experiences with pre-exposure prophylaxis in boston among lesbian, gay, bisexual, and transgender specialists and generalists in primary care: implications for scale-up. AIDS Patient Care STDS. 2017;31(7):297–304. doi:10.1089/apc.2017.0031
   PubMed Web of Science ®Google Scholar
• Newman R, Katchi T, Karass M, et al. Enhancing HIV pre-exposure prophylaxis practices via an educational intervention. Am J Ther. 2019;26(4):e462–e468. doi:10.1097/MJT.0000000000000773
   Web of Science ®Google Scholar
• Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. A simple pre-exposure prophylaxis (PrEP) optimization intervention for health care providers prescribing PrEP: pilot study. JMIR Form Res. 2018;2(1):e2. doi:10.2196/formative.8623
   Google Scholar
• Calabrese SK, Magnus M, Mayer KH, et al. Putting PrEP into practice: lessons learned from early-adopting U.S. providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS One. 2016;11(6):e0157324. doi:10.1371/journal.pone.0157324
   PubMed Web of Science ®Google Scholar
• Krakower DS, Oldenburg CE, Mitty JA, et al. Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: results from a survey of healthcare providers in New England. PLoS One. 2015;10(7):e0132398. doi:10.1371/journal.pone.0132398
   PubMed Web of Science ®Google Scholar
• Mullins TLK, Zimet G, Lally M, Kahn JA. Adolescent human immunodeficiency virus care providers’ attitudes toward the use of oral pre-exposure prophylaxis in youth. AIDS Patient Care STDS. 2016;30(7):339–348. doi:10.1089/apc.2016.0048
   PubMed Web of Science ®Google Scholar
• Mayer K, Chan P, Patel RR, Flash C, Krakower D. Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States. J Acquir Immune Defic Syndr. 2018;77(2):119–127. doi:10.1097/QAI.0000000000001579
   PubMed Web of Science ®Google Scholar
• Stinchcombe A, Wilson K. Lesian, gay, and bisexual (LGB) aging. In: Rania P, Wlfson C, Kirkland S, Griffith L, editors. The Canadian Longitudinal Study of Aging (CLSA) Report on Health and Aging in Canada, Findings from Baseline Data Collection 2010–2015. Hamilton, Ontario: Canadian Longitudinal Study of Aging; 2018:194–209.
   Google Scholar
• Community Based Research Centre. PrEP costs and coverage. PrEP Nova Scotia; 2018. Available from: https://prepnovascotia.ca/prescribing-prep/prep-costs-and-coverage/. Accessed June 12, 2020.
   Google Scholar
• Quon A. Advocates, NDP call for Nova Scotia to fund universal coverage of HIV prevention drug. Global News; 2019. Available from: https://globalnews.ca/news/6247947/universal-coverage-nova-scotia-hiv-prevention-drug/. Accessed June 12, 2020.
   Google Scholar
• BC Centre for Excellence in HIV/AIDS. BC first province to declare the end of AIDS as an Epidemic. BC; 2019. Available from: http://cfenet.ubc.ca/news/forecast/bc-first-province-declare-end-aids-epidemic. Accessed February 6, 2020.
   Google Scholar
• Flanagan T. The Wealth of First Nations. Fraser Institute; 2019.
   Google Scholar
• Silverman T, Schrimshaw E, Franks J, et al. Response rates of medical providers to internet surveys regarding their adoption of preexposure prophylaxis for HIV: methodological implications - Thomas B., Eric W. Schrimshaw, Julie Franks, Yael Hirsch-Moverman, Hugo Ortega, Wafaa M. El-Sadr, Paul W. Colson; 2018. Available from: https://journals.sagepub.com/doi/full/10.1177/2325958218798373?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed. Accessed February 6, 2020.
   Google Scholar